Advertisement

Combined modality therapy for rectal cancer

  • G. D. Beretta
  • S. Mosconi
  • L. Milesi
  • M. A. Pessi
  • R. Labianca
  • V. Valentini
  • M. Campitelli
  • G. Mantini
  • L. L. Gunderson
  • M. G. Haddock

Abstract

Rectal cancer is often a curable disease when localized. Although adenocarcinoma of the rectum and adenocarcinoma of the more proximal colon have a similar histologic appearance, the natural history of rectal and colon cancer differs, due to epidemiological, anatomical and pathophysiological reasons. In high-risk populations the incidence of colon and rectal tumors is 2:1, with rectal cancer that tends to be more frequent in males (20–50%).

Keywords

Rectal Cancer External Beam Radiation Therapy Total Mesorectal Excision Advanced Rectal Cancer Tumor Regression Grade 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. l.
    Compton CC, Fielding LP, Burgat LJ, et al. Prognostic factors in colorectal cancer: College of American Pathologist Consensus Statement 1999. Arch Pathol Lab Med 2000;124:979–994PubMedGoogle Scholar
  2. 2.
    Adam IJMM, Martin IG. Role of circumferential involvement in the local recurrence of rectal cancer. Lancet 1995;344:707–710Google Scholar
  3. 3.
    Nagtegaal ID, Van de Velde CJH, Van de Worp E, et al. Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol 2002;20:1729–1734PubMedGoogle Scholar
  4. 4.
    Dahlberg M, Pahlman L, Bergstrom R, et al. Improved survival in patients with rectal cancer: a population-based register study. Br J Surg 1998;85:515–520PubMedGoogle Scholar
  5. 5.
    Stocchi L, Nelson H, Sargent DJ, et al. North Central Cancer Treatment Group. Impact of surgical and pathologic variables in rectal cancer: a United States community and cooperative group report. J Clin Oncol 2001;19:3895–3902PubMedGoogle Scholar
  6. 6.
    Bleiberg H, Kemeny N, Rougier P, et al. Colorectal Cancer: a clinical guide to therapy. Martin Dunitz, London 2002, pp 173–184Google Scholar
  7. 7.
    Gunderson LL, Sosin H. Areas of failure found at reoperation (second or symptomatic look) following curative surgery for adenocarcinoma of rectum. Clinicapathological correlations and implications for adjuvant therapy. Cancer 1974;34:1278–1292PubMedGoogle Scholar
  8. 8.
    Obrand DI, Gordon PH, et al. Incidence and pattern of recurrence following curative resection for colorectal carcinoma. Dis Colon Rectum 1997;40:15–24PubMedGoogle Scholar
  9. 9.
    GITSG 7175: Prolongation of the disease-free interval in surgically treated rectal carcinoma. Gastrointestinal Tumor Study Group. N Engl J Med 1985;312:1465–1472Google Scholar
  10. 10.
    Valentini V, Miccichè F. Quali pazienti radiotrattare e quando. Tumori 2003;4:S87–S88Google Scholar
  11. 11.
    Minsky BD, Conti JA, Huang Y, et al. The relationship of acute gastrointestinal toxicity and volume of irradiated small bowel in patients receiving combined modality therapy for rectal cancer. J Clin Oncol 1995;13:1409–1416PubMedGoogle Scholar
  12. 12.
    Sitzler PJ, Seow-Choen F, Ho YH, et al. Lymph node involvement and tumor depth in rectal cancer: an analysis of 805 patients. Dis Colon Rectum 1997;40:1472–1476PubMedGoogle Scholar
  13. 13.
    Balslev I, Pedersen M, Teglbjaerg PS, et al. Postoperative radiotherapy in Dukes’B and C carcinoma of the rectum and rectosigmoid. Randomized multicen-ter study. Cancer 1986;58:22–28PubMedGoogle Scholar
  14. 14.
    Fisher B, Wolmark N, Rockette H, et al. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer. Results from NSABP protocol R-01. J Nat Cancer Inst 1988;80:21–29PubMedGoogle Scholar
  15. 15.
    Bentzen SM, Baslev I, Pedersen M et al. Time to locore-gional recurrence after resection of Dukes’B and C colorectal cancer with or without adjuvant postoperative radiotherapy. A multivariate regression analysis. Br J Cancer 1992;65:102–107PubMedGoogle Scholar
  16. 16.
    Treurniet Donker AD, Van Putten WL, Werwldsma JC. Postoperative radiation therapy for rectal cancer. An interim analysis of a prospective, randomized multicen-ter trial in the Netheralands. Cancer 1991;67:2028–2042Google Scholar
  17. 17.
    Arnaud JP, Nordlinger B, Bosset JF, et al. Radical surgery and postoperative radiotherapy as combined treatment in rectal cancer. Final results of phase III study of the European Organization for Research and treatment of Cancer. Br J Surg 1997;84:352–357PubMedGoogle Scholar
  18. 18.
    Medical Research Council Rectal Cancer Working Party. Randomized trial of surgery alone versus surgery followed by radiotherapy for mobile cancer of the rectum. Lancet 1996;348:1606–1610Google Scholar
  19. 19.
    Koelbl O, Richter S, Flentje M. Influence of patient positioning on dose-volume histogram and normal tissue complication probability for small bowel and bladder in patients receiving pelvic irradiation: a prospective study using a 3D planning system and a radiobiological model. Int J Radiat Oncol Biol Phys 1999;45:1193–1198PubMedGoogle Scholar
  20. 20.
    Byfield JE. Theoretical basis and clinical applications of 5-fluorouracil as a radiosensitizer. An overview. In Rotman M, Rosenthal CT (Eds): Concomitant continuous infusion chemotherapy and radiation. Springer Verlag, Berlin 1991, pp115–127Google Scholar
  21. 21.
    Lawrence TS, Maybaum J. Fluoropyrimidines as radiation sensitizer. Sem Radiot Oncol 1993;3:20–28Google Scholar
  22. 22.
    National Institute of Health Consensus Conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 1990;264:1444–1450Google Scholar
  23. 23.
    Krook JE, Moertel CG, Gunderson LL, et al. Effective surgical adjuvant therapy for high risk rectal carcinoma. N Engl J Med 1991;324:709–715PubMedGoogle Scholar
  24. 24.
    O’Connel MJ, Martenson JA, Wieand HS, et al. Improving radiation therapy for rectal cancer by combining protracted infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 1994;331:502–507Google Scholar
  25. 25.
    Wolmark N, Wieand HS, Hyams DM, et al. Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. J Nat Cancer Inst 2000;92:338–396Google Scholar
  26. 26.
    Tveit KM, Guldvog S, Hagen E, et al. Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer. Br J Surg 1997;84:1130–1135PubMedGoogle Scholar
  27. 27.
    GITSG 7180. Radiation therapy and fluorouracil with or without semustine for treatment of patients with surgical adjuvant adenocarcinoma of rectum. Gastrointestinal Tumor Study Group. J Clin Oncol 1992;10:549–557Google Scholar
  28. 28.
    Tepper JE, O’Connel M, Niedzwiecki D. Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control. Final report of Intergroup 0114. J Clin Oncol 2002;20:1774–1750Google Scholar
  29. 29.
    Lee HL, Lee JH, Ahn JH. Randomized trial of postoperative adjuvant therapy in stage II and III rectal cancer to define the optimal sequence of chemotherapy and radiotherapy: a preliminary report. J Clin Oncol 2002;20:1751–1758PubMedGoogle Scholar
  30. 30.
    Smaller SR, Benedetti J, Williamson J, et al. Intergroup 0144-phase III trial of 5FU based chemotherapy regimens plus radiotherapy (XRT) in postoperative adjuvant rectal cancer. Bolus 5FU vs. prolong venous infusion (PVI) before and after XRT + PVI vs. bolus 5FU + leucovorin (LV)+Levamisole (LEV) before and after XRT + bolus 5FU+LV. Proceedings of ASCO 2003;22: abstract n° 1006Google Scholar
  31. 31.
    Kapiteijn E, Corrie M, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001;34:638–646Google Scholar
  32. 32.
    Adam IJ, Mohamdee MO, Martin IG, et al. Role of the circumferential margin involvement in the local recurrence of rectal cancer. Lancet 1994;344:707–711PubMedGoogle Scholar
  33. 33.
    Tepper JE, O’Connell MJ, Niedwiecki D, et al. Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol 2001;19:157–163PubMedGoogle Scholar
  34. 34.
    Greene FL, Steward AK, Norton HJ, et al. A new staging strategy for node-positive stageIII rectal cancer: An analysis of 5988 patients. Proceedings of ASCO 2003;22: abstract n° 1007Google Scholar
  35. 35.
    Gunderson LL, Sargent D, Tepper J, et al. Impact of TN stage and treatment on survival and relapse in adjuvant rectal cancer pooled analysis. Proceedings of ASCO 2003;22:abstract n° 1008Google Scholar
  36. 36.
    Compton CC. Update protocol for the examination of specimens removed from patients with colorectal carcinoma. Arch Pathol Lab Med 2000;124:1016–1025PubMedGoogle Scholar
  37. 37.
    Compton CC, Fenoglio-Preiser CM, Pettigrew N, et al. American Joint Committee on Cancer Prognostic Factors Consensus Conference: Colorectal Working Group. Cancer SS 2000;1739–1757Google Scholar
  38. 38.
    Camma C, Giunta M, Fiorica F, Pagliaro L, et al. Preoperative radiotherapy for resectable rectal cancer. JAMA 2000;23:30Google Scholar
  39. 39.
    Colorectal Cancer Collaborative Group: Adjuvant radiotherapy for rectal cancer: A systematic overview of 8507 patients from 22 randomized trials. Lancet 2001;358:1291–1304Google Scholar
  40. 40.
    Minsky BD. Multidisciplinary management of resectable rectal cancer. Oncology 1996;10:1701–1714PubMedGoogle Scholar
  41. 41.
    Rosenthal CJ, et al. Concomitant continuous infusion chemotherapy and radiation, Springer Verlag, Berlin, 1991:1–9Google Scholar
  42. 42.
    Boulis-Wassif S, Gerard A, Loygue J, et al. Final results of a randomized trial on the treatment of rectal cancer with preoperative radiotherapy alone or in combination with 5-fluorouracil, followed by radical surgery. Trial of the European Organization on Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group. Cancer 1984;53:1811–1818PubMedGoogle Scholar
  43. 43.
    Mendenhall WM, Bland KI, Copeland EM 3rd, et al. Does preoperative radiation therapy enhance the probability of local control and survival in high-risk distal rectal cancer? Ann Surg 1992;215:696–705PubMedGoogle Scholar
  44. 44.
    Rich TA, Skibber JA et al: Preoperative infusional chemoradiation therapy for stage T3 rectal cancer. Int J Radiat Onc Biol Phys 1995;32:1025–1029Google Scholar
  45. 45.
    Chan A, Wong A, Langevin J, Khoo R. Preoperative concurrent 5FU infusion, mitomycin and pelvic radiation therapy in tethered and fixed rectal carcinoma. Int J Radiat Oncol Biol Phys 1993;25:791–799PubMedGoogle Scholar
  46. 46.
    Minsky BD, Cohen AM, Enker WE, et al. Preoperative 5FU, low-dose leucovorin and radiation therapy for locally advanced and unresectable rectal cancer. Int J Radiat Oncol Biol Phys 1997;40:515–522Google Scholar
  47. 47.
    Enami B, Pilepich M, Willett C, et al. Effect of preoperative irradiation on resectability of colorectal carcinomas. Int J Radiat Oncol Biol Phys 1982;8:1335–1339Google Scholar
  48. 48.
    Bosset JF, Pavy JJ, Hamers HP, et al. Determination of the optimal dose of 5-fluorouracil when combined with low-dose D,L-Leucovorin and irradiation in rectal cancer: results of 3 consecutive Phase II studies. Eur J Cancer 1993;33A:1406–1410Google Scholar
  49. 49.
    Minsky BD, Cohen AM, Enker WE, et al. Combined modality therapy of rectal cancer. Decreased acute toxicity with the preoperative approach. J Clin Onc 1992;10:1218–1224Google Scholar
  50. 50.
    Roh MS, Petrelli N, Wieand S, et al. Phase III randomized trial of preoperative versus postoperative multi-modality therapy in patients with carcinoma of the rectum (NSABP R-03). Proceedings of ASCO 2001, abstract n°490Google Scholar
  51. 51.
    Ahmed, et al. Pathologic complete response predicts long-term survival following preoperative radiation therapy for rectal cancer. Int J Radiat Oncol Biol Phis 1997;39:284, abstract n°2087Google Scholar
  52. 52.
    Graf W, Dahlberg M, Osman MM, et al. Short-term preoperative radiotherapy results in downstaging of rectal cancer: a study of 1316 patients. Rad Oncol 1997;43:133–137Google Scholar
  53. 53.
    Omura M, Torigoe S, Kubota N. SN-38, a metabolite of the camptothecin derivative CPT-11, potentiates the cytotoxic effect of radiation in human colon adenocarcinoma cells grown as spheroids. Radiother Oncol 1997;43:197–201PubMedGoogle Scholar
  54. 54.
    Hess S. Oxaliplatin: In vitro and in vivo evidence of its radiation sensitizing activity-preclinical observations relevant to ongoing clinical trials. Proc AACR 2000; 41:A335Google Scholar
  55. 55.
    Mitchell EP, Anne PR, Fry R, et al. Chemoradiation with CPT11, 5FU in neoadjuvant treatment of locally advanced or recurrence adenocarcinoma of the rectum: A phase I/II study update. Proceedings of ASCO 2003;22:abstract n° 1052Google Scholar
  56. 56.
    Dunst J, Reese T, Hoelscher T, et al. Capecitabine combined with radiotherapy as neoadjuvant treatment of locally advanced rectal cancer. locally advanced rectal cancer. Proceedings of ASCO 2003;22: abstract n° 1113Google Scholar
  57. 57.
    Lin EH, Skibber J, Delcos M, et al. A phase II study of capecitabine and radiotherapy plus concomitant boost in patients (pts) with locally advanced rectal cancer (LARC): Preliminary safety analysis. Proceedings of ASCO 2003;22:abstract n° 1152Google Scholar
  58. 58.
    Glynne-Jones R, Sebag-Motefiore D, Mc Donald A, et al. A phase I study of preoperative radiation and capecitabine in combination with oxaliplatin in locally advanced rectal cancer. Proceedings of ASCO 2003;22:abstract n° 1174Google Scholar
  59. 59.
    Rosenthal DI, Catalano P, Haller DG, et al. ECOG 1297: A phase I study of preoperative radiation therapy (RT) with concurrent protracted continuous infusion 5FU and dose escalating oxaliplatin followed by surgery, adjuvant 5FU, and leucovorin for locally advanced (T3/4) rectal adenocarcinoma. adjuvant 5FU, and leucovorin for locally advanced (T3/4) rectal adenocarcinoma. Proceedings of ASCO 2003;22:abstract n° 1094Google Scholar
  60. 60.
    Casado E, De Castro J, Feliu J, et al. Neoadjuvant therapy of rectal carcinoma with oxaliplatin and raltitrexed plus radiotherapy. Proceedings of ASCO 2003;22:abstract n° 1342Google Scholar
  61. 61.
    Balch GC, Mithani SK, Shyr Y, et al. Prognostic significance of response to neoadjuvant chemoradiation therapy for rectal cancer. Proceedings of ASCO 2003;22:abstract n° 1047Google Scholar
  62. 62.
    Gemici C, Mayadagli A, Marti A, et al. Preoperative radiation in combination with 5-fluorouracil, mitomycin-C and interferon a in locally advanced rectal adenocarcinoma. Proceedings of ASCO 2003;22: abstract n° 1308Google Scholar
  63. 1.
    Janjan NA, Abbruzzese J, Pazdur R, Khoo VS, Cleary K, Dubrow R, Ajani J, Rich TA, Goswitz MS, Evetts PA, Allen PK, Lynch PM, Skibber JM Prognostic implications of response to preoperative infusional chemora-diation in locally advanced rectal cancer. Radiother Oncol 1999;51:153–160PubMedGoogle Scholar
  64. 2.
    Berger C, de Muret A, Garaud P, Chapet S, Bourlier P, Reynaud-Bougnoux A, Dorval E, de Calan L, Huten N, le Folch O, Calais G. Preoperative radiotherapy (RT) for rectal cancer: predictive factors of tumor downstaging and residual tumor cell density (RTCD): prognostic implications. Int J Radiat Oncol Biol Phys 1997; 37:619–627PubMedGoogle Scholar
  65. 3.
    Kaminsky-Forrett MC, Conroy T, Luporsi E, Peiffert D, Lapeyre M, Boissel P, Guillemin F, Bey P Prognostic implications of downstaging following preoperative radiation therapy for operable T3–T4 rectal cancer. Int J Radiat Oncol Biol Phys 1998;42:935–941PubMedGoogle Scholar
  66. 4.
    Mohiuddin M, Hayne M, Regine WF, Hanna N, Hagihara PF, McGrath P, Marks GM Prognostic significance of postchemoradiation stage following preoperative chemotherapy and radiation for advanced/recurrent rectal cancers. Int J Radiat Oncol Biol Phys 2000;48:1075–1080PubMedGoogle Scholar
  67. 5.
    Vecchio FM, Valentini V, Padula G, Venkatraman E, Fares MC, Miccichè F, Ricci R, Moranti AG, Gambacorta MA, Maurizi F, Minsky BD, Coco C. A pathologic score system after preoperative combined modality therapy as a predictor of metastases free survival in the management of rectal carcinoma. Int J Radiat Oncol Biol Phys 2002;54:207Google Scholar
  68. 6.
    Mandard AM, Dalibard F, Mandard JC, Marnay J, Henry-Amar M, Petiot JF, Roussel A, Jacob JH, Segol P, Samama G, Ollivier JM, Bonvalot S, Gignoux M. Pathologic assessment of Tumor Regression Grade after preoperative chemoradiotherapy of esophageal carcinoma; Cancer 1994;73:2680–2686PubMedGoogle Scholar
  69. 7.
    Skibber JM, Hoff PM, Minsky BD. Cancer of the rectum in De Vita V, Hellman S, Rosemberg SA: Cancer, principle & practice of oncology’ 6th edition, Lippincott Williams & Wilkins Eds, Philadelphia, 2001, 1271–1319Google Scholar
  70. 8.
    Cionini L, Cartei F, Manfredi B, Laliscia C, Sainato A, Valentini V, Lupattelli M, Pizzi GB, Osti M, Santoni R. Randomized study of preoperative chemoradiation (CTRT) in locally advanced rectal cancer. Preliminary results Int J Radiat Oncol Biol Phys 1999;545: supplement 178Google Scholar
  71. 9.
    Valentini V, Coco C, Cellini N, Picciocchi A, Genovesi D, Mantini G, Barbaro B, Cogliandolo S, Mattana C, Ambesi-Impiombato F, Tedesco M, Cosimelli M. Preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation. Int J Radiat Oncol Biol Phys 1998;40:1067–1075PubMedGoogle Scholar
  72. 10.
    Valentini V, Coco C, Cellini N, Picciocchi A, Fares MC, Rosetto ME, Mantini G, Morganti AG, Barbaro B, Cogliandolo S, Nuzzo G, Tedesco M, Ambesi-Impimbato F, Cosimelli M, Rotman M. Ten years of preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response and sphincter preservation in three years consecutive studies. Int J Radiat Oncol Biol Phis 2001;51,2:371–383Google Scholar
  73. 11.
    Gambacorta MA, Valentini V, Morganti AG, Mantini G, Miccichè F, Ratto C, Di Miceli D, Rotondi F, Alfieri S, Doglietto GB, De Paoli A, Rossi C, Cellini N. Chemoradiation with Raltitrexed (‘Tomudex’) in preoperative treatment of stage II/III resectable rectal cancer: A Phase II Study (In press).Google Scholar
  74. 12.
    Gambacorta MA, Valentini V, Morganti AG, Smaniotto D, Miccichè F, Mantini G, Barbaro B, Garcia-Vargas JE, Coco C, Cogliandolo S, Picciocchi A, Cellini N. Chemoradiation with Raltitrexed and Oxaliplatin in preoperative treatment of stage II/III resectable rectal cancer: A Phase I and A Phase II Studies (In press).Google Scholar
  75. 1.
    Comas C, Priò A. Irradiation roentgen préventive intra-abdominale, aprés l’intervention chirurgicale dans un cas de cancer de l’uterus. Communication an III an. Congres International d’Electròlogie 1906. Barcelona: Imprenta Francesco Badia 1907; 5–14Google Scholar
  76. 2.
    Beck C. On external roentgen treatment of internal structures (eventration treatments). NY Med J 1909; 89:621Google Scholar
  77. 3.
    Eloesser L. The treatment of some abdominal cancers by irradiation through the open abdomen combined with cautery excision. Ann Surg 1937; 106:645–652PubMedGoogle Scholar
  78. 4.
    Barth G. Erfahrungen und Ergebnisse mit der Nahbestrahlung operative freigeleger Tumor. Strahlentherapie 1959; 91:481–527Google Scholar
  79. 5.
    Abe M, Takahashi M. Intraoperative radiotherapy: the Japanese experience. Int J Radiat Oncol Biol Phys 1981; 7:863–868PubMedGoogle Scholar
  80. 6.
    Goldson A. Preliminary clinical experience with intraoperative radiotherapy. J Nat Med Assoc 1978; 70:408–416Google Scholar
  81. 7.
    Willet CG, Gunderson LL, Busse PM, Nagorney D, Tepper JE, Calvo FA. IOERT treatment factor. In: Current Clinical Oncology: Intraoperative Irradiation: Techniques and Results. Ed. Gunderson LL, et al. Totowa, NJ: Humana Press 1999.Google Scholar
  82. 8.
    Tepper JE, Gunderson LL, Goldson AL, et al. Quality control parameters of intraoperative radiation therapy. Int J Radiat Oncol Biol Phys 1986; 12:1687–1695PubMedGoogle Scholar
  83. 9.
    Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int Radiat Oncol Biol Phys 1991; 21:109–122Google Scholar
  84. 10.
    Sindelar WF, Johnstone PAS, Hoekstra HJ, Kinsella TJ. Normal tissue tolerance to intraoperative irradiation. In: Current Clinical Oncology: Intraoperative Irradiation: Techniques and Results. Ed. Gunderson LL, et al. Totowa, NJ: Humana Press 1999.Google Scholar
  85. 11.
    Gunderson LL. Past, present and future of intraoperative irradiation for colorectal cancer. Int J Radiation Oncol Biol Phys 1996;34:741–744Google Scholar
  86. 12.
    Gunderson LL, Cohen AM, Dosoretz DE, et al. Residual, unresectable, or recurrent colorectal cancer: external beam irradiation and intraoperative electron beam boost ± resection. Int J Radiat Oncol Biol Phys 1983;9:1597–1606PubMedGoogle Scholar
  87. 13.
    Willett CG, Shellito PC, Tepper JE, Eliseo R, Convery K, Wood WC. Intraoperative electron beam radiation therapy for primarily locally advanced rectal and rectosigmoid carcinoma. J Clin Oncol 1991;9:843–849PubMedGoogle Scholar
  88. 14.
    Gunderson LL, Martin JK, Beart RW, et al. External beam intraoperative electron irradiation for locally advanced colorectal cancer. Ann Surg 1988;207:52–60PubMedGoogle Scholar
  89. 15.
    Gunderson LL, Nelson H, Martenson JA, et al. Locally advanced primary colorectal cancer: intraoperative electron and external beam irradiation ± 5Fu. Int J Radiat Oncol Biol Phys 1997;37:601–614PubMedGoogle Scholar
  90. 16.
    Azinovic I, Calvo FA, Aristu JJ, et al. Intraoperative radiation therapy as a treatment component in primary rectal cancer: ten-year experience. (Personal Communication)Google Scholar
  91. 17.
    Valentini V, Morganti AG, De Franco A, et al. Chemoradiation with or without intraoperative radiation therapy in patients with locally recurrent rectal carcinoma: prognostic factors and long term outcome. Cancer 1999;86:2612PubMedGoogle Scholar
  92. 18.
    Wallace HJ., Willet CG., Shellito PC, Coen JJ., Hoover HC. Intraoperative radiation therapy for locally advanced recurrent rectal or rectosigmoid cancer. J Surg Oncol 1995;60:122–127PubMedGoogle Scholar
  93. 19.
    Gunderson LL, Nelson H, Martenson JA, Cha S, Haddock M et al. Intraoperative electron and external beam irradiation with or without 5-fluorouracil and maximum surgical resection for previously unirradiated, locally recurrent colorectal cancer. Dis Colon Rectum 1996;39:1379–1395PubMedGoogle Scholar
  94. 20.
    Farouk R, Nelson H, Gunderson LL. Aggressive multi-modality treatment for locally advanced irresectable rectal cancer. Br J Surg 1997;84:741–749PubMedGoogle Scholar
  95. 21.
    Suzuki K, Gunderson LL, Devine RM, et al. Reoperation ± irradiation for locally recurrent rectal cancer. Cancer 1995;8:118–127Google Scholar
  96. 22.
    Lindel K, Willett CG, Shellito PC et al: Intraoperative radiation therapy for locally advanced recurrent rectal or rectosigmoid cancer. Radiother Oncol 2001;58:83–87PubMedGoogle Scholar
  97. 23.
    Wiig JN, Tveit KM et al. Preoperative irradiation and surgery for recurrent rectal cancer. Will intraoperative radiotherapy (IORT) be of additional benefit? A prospective study. Radiother Oncol 2002;62:207–213PubMedGoogle Scholar
  98. 24.
    Haddock MG, Nelson H, Donohue JH et al. Intraoperative electron radiotherapy as a component of salvage therapy for patients with colorectal cancer and advanced nodal metastases. Int J Radiat Oncol Biol Phys 2003;56:966–973PubMedGoogle Scholar
  99. 1.
    Fletcher GH, Shukovsky LJ. The interplay of radiocur-ability and tolerance in the irradiation of human cancers. J Radiol Electrol 1975;56:383–400PubMedGoogle Scholar
  100. 2.
    Suit HD. Local control and patient survival. Int J Radiat Oncol Biol Phys 1992;23:653–660PubMedGoogle Scholar
  101. 3.
    Gunderson LL, Tepper JE, Biggs DJ, et al. Intraoperative ± external beam irradiation Curr Probl Cancer 1983;7:1–69PubMedGoogle Scholar
  102. 4.
    Gunderson LL, Willett CG, Harrison LB, Calvo F. Intraoperative irradiation: Techniques and results. Humana Press 1999;1–550Google Scholar
  103. 5.
    Gunderson LL, Martenson JA. Gastrointestinal tract radiation tolerance. In: Radiation Tolerance of Normal Tissues. Ed. Vaeth JM and Meyer JE. Karger, Basel. Front Radiat Ther Oncol 1989;23:277–298Google Scholar
  104. 6.
    Okunieff P, Sundararaman S, Chen Y. Biology of large dose per fraction radiation therapy. In: Intraoperative Irradiation: Techniques and Results. Ed. Gunderson LL et al. Totowa, NJ: Humana Press 1999;25–46Google Scholar
  105. 7.
    Tepper JE, Gunderson LL, Goldson AL, et al. Quality control parameters in intraoperative radiation therapy. Int J Radiat Oncol Biol Phys 1986;12:1687–1695PubMedGoogle Scholar
  106. 8.
    Sindelar WE, Johnston PA, Hoekstra H, Kinsella TJ. Normal tissue tolerance to intraoperative irradiation: The National Cancer Institute experimental Studies. In: Intraoperative Irradiation: Techniques and Results. Ed. Gunderson LL et al. Totowa, NJ: Humana Press 1999;131–146Google Scholar
  107. 9.
    Gillette EL, Gillette SM, Powers BE. Studies at Colorado State University of normal tissue tolerance of beagles to IOERT, EBRT, or a combination. In: Intraoperative Irradiation: Techniques and Results. Ed. Gunderson LL et al. Totowa, NJ: Humana Press 1999;147–164Google Scholar
  108. 10.
    Gillette EL, Powers BE, Gillette SM, Gunderson LL, Willett C. Peripheral nerve tolerance: experimental and clinical. In: Intraoperative Irradiation: Techniques and Results. Ed. Gunderson LL et al. Totowa, NJ: Humana Press 1999;165–174Google Scholar
  109. 11.
    Gunderson LL, Nelson H, Martenson J, et al. Locally advanced primary colorectal cancer: intraoperative electron and external beam irradiation ± 5FU. Int J Radiat Oncol Biol Phys 1997;37:601–614PubMedGoogle Scholar
  110. 12.
    Gunderson LL, Nelson H, Martenson J, et al. Intraoperative electron and external beam irradiation with or without 5-fluouracil and maximal surgical resection for previously unirradiated, locally recurrent colorectal cancer. Dis Colon Rectum 1996;39:1379–1395PubMedGoogle Scholar
  111. 13.
    Willett CG, Shellito PC, Gunderson LL. Primary colorectal EBRT and IOERT. In Intraoperative Irradiation: Techniques and Results. Ed. Gunderson LL et al. Totowa, NJ: Humana Press 1999;249–272Google Scholar
  112. 14.
    Schild SE, Gunderson LL, Haddock MG et al. The treatment of locally advanced colon cancer. Int J Radiat Oncol Biol Phys 1997;37:51–58PubMedGoogle Scholar
  113. 15.
    Haddock MG, Nelson H, Donohue JH et al. Intraoperative electron radiotherapy as a component of salvage therapy for patients with colorectal cancer and advanced nodal metastases. Int J Radiat Oncol Biol Phys 2003;56:966–973PubMedGoogle Scholar
  114. 16.
    Gunderson LL, Willett CG, Haddock MG et al. Recurrent colorectal: EBRT with or without IOERT or HDR-IORT. In: Intraoperative Irradiation: Techniques and Results. Ed. Gunderson LL et al. Totowa, NJ: Humana Press 1999;273–306Google Scholar
  115. 17.
    Suzuki K, Gunderson LL, Devine RM, et al. Intraoperative irradiation after palliative surgery for locally recurrent rectal cancer. Cancer 1995;75:939–952PubMedGoogle Scholar
  116. 18.
    Haddock M, Gunderson L, Nelson H, et al. Intraoperative irradiation for locally recurrent colorectal cancer in previously irradiated patients. Int J Radiat Oncol Biol Phys 2001;49:1267–1274PubMedGoogle Scholar
  117. 19.
    Haddock MG, Miller RC, Nelson H, Devine RM, Gunderson LL. Intraoperative electron irradiation for locally recurrent rectal cancer. ISIORT 2002, Aachen. Abstract 8.3Google Scholar
  118. 20.
    Abuchaibe O, Calvo FA, Azinovic I et al. Intraoperative radiotherapy in locally advanced recurrent colorectal cancer. Int J Radiat Oncol Biol Phys 1993;26:859–867PubMedGoogle Scholar
  119. 21.
    Bussieres E, Gilly FN, Rouanet P, et al. Recurrences of rectal cancers: result of a multimodal approach with intraoperative radiation therapy. Int J Radiat Oncol Biol Phys 1996;34:49–56PubMedGoogle Scholar
  120. 22.
    Mannaerts GHH, Martijn H, Crommelin MA, et al. Intraoperative electron beam radiation therapy for locally recurrent rectal carcinoma. Int J Radiat Oncol Biol Phys 1999;45:297–308PubMedGoogle Scholar
  121. 23.
    Harrison L, Minsky BD, White C, Cohen AM, Enker, WE. HDR-IORT for colorectal cancer. In: Intraoperative Irradiation: Techniques and Results. Ed. Gunderson LL et al. Totowa, NJ: Humana Press 1999; 307–314Google Scholar
  122. 24.
    Gunderson LL, Willett CG, Calvo FA, Harrison LB. Conclusions and future possibilities. In: Intraoperative Irradiation: Techniques and Results. Ed. Gunderson LL et al. Totowa, NJ: Humana Press 1995;527–536Google Scholar
  123. 25.
    Meurk ML, Goer DA, Spalek G, Cock T. The Mobetron: a new concept for intraoperative radiotherapy. In: Role of Intraoperative Radiation Therapy in the Treatment of Cancer Ed. Vaeth J and Meyer J. S Karger: Basel. Front Radiat Ther Oncol 1997;31:65–70Google Scholar
  124. 26.
    Fantini M, Santori F, Soriani A, et al. IORT — Novac 7, a linear accelerator for electron beam therapy. Abstract in 6th International Symposium of IORT, San Francisco, 1996Google Scholar

Copyright information

© Springer-Verlag Italia 2004

Authors and Affiliations

  • G. D. Beretta
  • S. Mosconi
  • L. Milesi
  • M. A. Pessi
  • R. Labianca
  • V. Valentini
  • M. Campitelli
  • G. Mantini
  • L. L. Gunderson
  • M. G. Haddock

There are no affiliations available

Personalised recommendations